Jaume Mora Graupera
Jefe de Grupo Senior
Research group
Professional network profiles
Last Publications
- Hernandez-Munoz, Inmaculada, Cuervas, Irene, Prada, Estela, Pulecio, Julian, Giemno, Ramon, Andrades, Evelyn, Gomez-Gonzalez, Soledad, Berenguer-Molins, Pau, Acedo-Terrades, Ariadna, Perera-Bel, Julia, Bodalo, Marta, Nonell, Lara, Perez, Elena, Grases, Daniela, Mata, Caterina, Yelamos, Jose, Richaud, Yvonne, Vidal, Enrique, Cuartero, Yasmina, Le Dily, Francois, Sunol, Mariona, Manzanares, Alejandro, Raya, Angel and Mora J EWS-FLI1 Expression in Human Embryonic MSCs Leads to Transcriptional Reprograming, Defective DNA Damage Repair and Ewing Sarcoma Biorxiv . : .
- Krauel L, Pasten A, Gorostegui M, Mañé S, Martin Giménez MP, Coronas-Soucheiron M, Carrasco-Torrents R and Mora J Use of Radioguided Surgery for Small and Difficult-to-Locate Relapsed MIBG (+) High-Risk Neuroblastoma Lesions Cancers . 16(19): .
- Cristina Larrosa Espinosa, Mico S, Ramos M, Pérez-Jaume S, Sánchez M, Castañeda-Heredia A, Garraus-Oneca M and Mora J Radiation recall reaction induced by gemcitabine/docetaxel in children: A retrospective study on risk factors and outcomes PEDIATRIC BLOOD & CANCER . 71(10): .
Projects
- Project name:
- ADVANCED THERAPIES (RICORS-TERAV)
- Leader
- Susana Rives Solà
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- RD24/0014/0006
- Starting - finishing date:
- 2025 - 2027
- Project name:
- Disrupción de enhancers: la nueva generación de terapia epigenética en el sarcoma de Ewing
- Leader
- Jaume Mora Graupera, Sara Sánchez Molina
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- PI24/00804
- Starting - finishing date:
- 2025 - 2027
- Project name:
- Ensayo clínico de seguridad y factibilidad de inmunoterapia celular: Células dendríticas autólogas pulsadas con un lisado de líneas tumorales alogénicas, asociadas con CART anti-IL13Ra2 en pacientes con tumor difuso intrínseco de tronco (DIPG) (fase Ib)
- Leader
- Andrés Morales La Madrid
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- ICI23/00063
- Starting - finishing date:
- 2024 - 2027
News
-
New discoveries about the EWS-FLI oncogene involved in the development of Ewing's tumor
Researchers from IRSJD · SJD Barcelona Children’s Hospital and IRB Barcelona have successfully developed Drosophila models expressing the EWS-FLI oncogene at varying levels, overcoming previous toxicity challenges and enabling detailed study of Ewing sarcoma's oncogenic pathways.
-
Researchers from IRSJD and IRB Barcelona unveil the origin of second pediatric cancers and chemotherapy-induced mutations in healthy tissues
A team from Institut de Recerca Sant Joan de Déu and IRB Barcelona has studied the cases of four children who have experienced two cancers during childhood and has addressed the origin of the second tumour. The work has been published in the journal Cancer Discovery.
-
New research facilities for studying children's cancer
New facilities have been opened for the children's oncology laboratory of the Institut de Recerca Sant Joan de Déu - SJD Barcelona Children's Hospital to celebrate 20 years of research. These laboratories are unique in their exclusive dedication to pediatric tumors and have over 50 researchers who focus on the study of more than ten developmental tumors.
More activities
-
Defensa tesi doctoral: Irene Cuervas Oliveras
Auditori Plaza · Hospital Sant Joan de Déu
-
Defensa tesi doctoral: María Sánchez Jiménez
Auditori Plaza · Hospital Sant Joan de Déu and online
-
First International Symposium on Transdisciplinary Approaches for Neuroblastoma Therapy
Auditorium SJD Pediatric Cancer Center Barcelona